KONDO Hiromu 近藤啓

… Alternative Names

Kondo Hiromu 近藤啓

Less

Researcher Number	60750594
Other IDs
Affiliation (Current)	2025: 名古屋市立大学, 医薬学総合研究院(医学), 准教授
Affiliation (based on the past Project Information) *help	2021 – 2023: 名古屋市立大学, 医薬学総合研究院(医学), 准教授
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related / 0901:Oncology and related fields
Keywords	Principal Investigator オートタキシン / 膵神経内分泌腫瘍 / 胆道癌

膵神経内分泌腫瘍における新規Theragnostic targetの解明：オートタキシンへの期待Principal Investigator
- Principal Investigator
  
  近藤啓
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Nagoya City University
Development of Novel Therapies Targeting ATX/LPA Receptor Signaling in CholangiocarcinomaPrincipal Investigator
- Principal Investigator
  
  Kondo Hiromu
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Review Section
  
  0901:Oncology and related fields
- Research Institution
  Nagoya City University

All 2024 2023 2022

All Journal Article

[Journal Article] Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study2024
- Author(s)
  Suzuki Takanori、Kimura Yoshihide、et al.
- Journal Title
  
  Oncology
  
  Volume: Online ahead of print Issue: 8 Pages: 1-12
- DOI
  10.1159/000536367
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K20906, KAKENHI-PROJECT-23K07359, KAKENHI-PROJECT-21K20844
[Journal Article] The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis2023
- Author(s)
  Matoya Sho、、Kimura Yoshihide、et al.
- Journal Title
  
  Hepatology Research
  
  Volume: 53 Issue: 6 Pages: 511-521
- DOI
  10.1111/hepr.13886
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K20906, KAKENHI-PROJECT-23K07359, KAKENHI-PROJECT-21K20844
[Journal Article] Dual role of autotaxin as novel biomarker and therapeutic target in pancreatic neuroendocrine neoplasms2023
- Author(s)
  Toyohara Tadashi、Yoshida Michihiro
- Journal Title
  
  Cancer Science
  
  Volume: 114 Issue: 12 Pages: 4571-4582
- DOI
  10.1111/cas.15980
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K07399, KAKENHI-PROJECT-23K07444, KAKENHI-PROJECT-20K08291, KAKENHI-PROJECT-21K20844, KAKENHI-PROJECT-21H03006
[Journal Article] Clinical impact of bile‐derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers2022
- Author(s)
  Yoshida Michihiro、Yukawa Hiroshi、Hayashi Kazuki、et al.
- Journal Title
  
  Cancer Science
  
  Volume: 114 Issue: 1 Pages: 295-305
- DOI
  10.1111/cas.15597
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08291, KAKENHI-PROJECT-21K20844, KAKENHI-PUBLICLY-21H05589, KAKENHI-PROJECT-17K09479

1. 吉田道弘 (20636328)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
2. 木村吉秀

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

KONDO Hiromu 近藤啓

Kondo Hiromu 近藤啓

Research Projects

Research Products

Co-Researchers

膵神経内分泌腫瘍における新規Theragnostic targetの解明：オートタキシンへの期待Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of Novel Therapies Targeting ATX/LPA Receptor Signaling in CholangiocarcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dual role of autotaxin as novel biomarker and therapeutic target in pancreatic neuroendocrine neoplasms2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical impact of bile‐derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers2022

Author(s)

Journal Title

DOI

Data Source

KONDO Hiromu 近藤 啓

Kondo Hiromu 近藤 啓

Research Projects

Research Products

Co-Researchers

膵神経内分泌腫瘍における新規Theragnostic targetの解明：オートタキシンへの期待Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of Novel Therapies Targeting ATX/LPA Receptor Signaling in CholangiocarcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dual role of autotaxin as novel biomarker and therapeutic target in pancreatic neuroendocrine neoplasms2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical impact of bile‐derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers2022

Author(s)

Journal Title

DOI

Data Source

KONDO Hiromu 近藤啓

Kondo Hiromu 近藤啓